Invasive Lobular Breast Carcinoma: Clinical Trials

1 trial for Invasive Lobular Breast Carcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Active not recruiting 1

Follow Invasive Lobular Breast Carcinoma: new trials by email Literature Review of Invasive Lobular Breast Carcinoma trials Research Report on Invasive Lobular Breast Carcinoma

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery
fulvestrant, anastrozole - Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer
Phase 3Active not recruitingAlliance for Clinical Trials in Oncology14732014-02-272026-06-05

Narrower conditions

Breast Neoplasms (1)  ·  Carcinoma, Ductal, Breast (1)  ·  Carcinoma, Lobular (1)

Broader conditions

Adenocarcinoma (1)  ·  Breast Diseases (1)  ·  Carcinoma (1)  ·  Carcinoma, Ductal (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Ductal, Lobular, and Medullary (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Skin Diseases (1)  ·  Skin and Connective Tissue Diseases (1)

Interventions

Anastrozole (1)  ·  Fulvestrant (1)

Sponsors

Alliance for Clinical Trials in Oncology (1)

Countries

Puerto Rico (1)  ·  United States (1)

Top investigators

Cynthia Ma, MD, PhD (1)

Results publications

PMID 28045625, PMID 38236590

NIH funding

U10CA031946 (1)